Treatment of membrane-associated diseases and disorders using lantibiotic containing compositions
US7326683B2 · kind B2 · utility
1Cited by
48References
19Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | May 6, 2005 |
| Grant date | Feb 5, 2008 |
| Priority date | — |
| Expiry date | Jun 4, 2025 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P9/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compositions useful for treating membrane-associated diseases, conditions, and disorders, including inflammatory diseases, dry mouth, primary ciliary dyskinesia and platelet aggregating disorders, are disclosed which comprise at least one lantibiotic compound. Also disclosed are pharmaceutical compositions and methods of treatment for membrane-associated diseases such as inflammation and dermal irritation, as well as use of such compositions in the treatment of membrane-associated diseases, wherein the pharmaceutical compositions contain at least one lantibiotic.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.